Literature DB >> 19294416

Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma.

C Uzan1, E Darai, A Valent, O Graesslin, A Cortez, R Rouzier, P Vielh.   

Abstract

A role for the EGF system, in particular HER1 and 2, in growth of the endometrium has been suggested but HER1 and 2 have not been studied in all locations of endometriosis and in ovarian endometrioid adenocarcinoma (OEC) which is a rare form of malignant transformation of endometriosis. Immunohistochemistry (IHC) was used for studying HER1 and HER2 in ovarian (n = 10), peritoneal (n = 10), colorectal endometriosis (n = 20) and OEC (n = 10). Fluorescent in situ hybridisation (FISH) was used for analysing the status of HER2 gene in colorectal endometriosis and OEC. All samples were negative for HER2 in both glandular and stromal cells and in glandular cells for HER1 by IHC. In 15 out of 20 colorectal endometriosis, there was a weak expression in stromal cells. Following FISH, two colorectal samples had a partial 17 aneusomy and three OEC, a 17 polysomy. The other samples were 17 disomic without HER2 amplification; HER1 and 2 do not seem to have a role in endometriosis physiopathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294416     DOI: 10.1007/s00428-009-0755-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  31 in total

Review 1.  Biologic and immunologic therapies for ovarian cancer.

Authors:  Jonathan S Berek; Birgit C Schultes; Christopher F Nicodemus
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544

Review 2.  Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy.

Authors:  Paul A Bunn; Rafal Dziadziuszko; Marileila Varella-Garcia; Wilbur A Franklin; Samir E Witta; Karen Kelly; Fred R Hirsch
Journal:  Clin Cancer Res       Date:  2006-06-15       Impact factor: 12.531

3.  Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain.

Authors:  D W Stovall; L M Bowser; D F Archer; D S Guzick
Journal:  Fertil Steril       Date:  1997-07       Impact factor: 7.329

4.  Quality of life after laparoscopic colorectal resection for endometriosis.

Authors:  Gil Dubernard; Mathilde Piketty; Roman Rouzier; Sydney Houry; Marc Bazot; Emile Darai
Journal:  Hum Reprod       Date:  2006-01-26       Impact factor: 6.918

5.  The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer.

Authors:  Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Shigematsu; Masaki Tokumo; Junichi Soh; Hiroaki Asano; Kouichi Ichimura; Keisuke Aoe; Motoi Aoe; Katsuyuki Kiura; Kenji Shimizu; Hiroshi Date; Nobuyoshi Shimizu
Journal:  Int J Cancer       Date:  2007-03-15       Impact factor: 7.396

6.  EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.

Authors:  Rohit Bhargava; William L Gerald; Allan R Li; Qiulu Pan; Priti Lal; Marc Ladanyi; Beiyun Chen
Journal:  Mod Pathol       Date:  2005-08       Impact factor: 7.842

7.  Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer.

Authors:  Vassiliki Malamou-Mitsi; Olga Crikoni; Eleni Timotheadou; Gerassimos Aravantinos; Eleni Vrettou; Niki Agnantis; George Fountzilas
Journal:  Anticancer Res       Date:  2007 Mar-Apr       Impact factor: 2.480

8.  Immunohistochemical investigation and northern blot analysis of c-erB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri.

Authors:  C Brumm; A Rivière; C Wilckens; T Löning
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

9.  Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.

Authors:  H Niikura; H Sasano; K Kaga; S Sato; A Yajima
Journal:  Hum Pathol       Date:  1996-03       Impact factor: 3.466

10.  Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Authors:  M F Press; C Cordon-Cardo; D J Slamon
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

View more
  4 in total

Review 1.  HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies.

Authors:  Diana P English; Dana M Roque; Alessandro D Santin
Journal:  Mol Diagn Ther       Date:  2013-04       Impact factor: 4.074

2.  ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling.

Authors:  Miles A Miller; Aaron S Meyer; Michael T Beste; Zainab Lasisi; Sonika Reddy; Karen W Jeng; Chia-Hung Chen; Jongyoon Han; Keith Isaacson; Linda G Griffith; Douglas A Lauffenburger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-14       Impact factor: 11.205

Review 3.  Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Authors:  Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

4.  Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis.

Authors:  V Janša; T Klančič; M Pušić; M Klein; E Vrtačnik Bokal; H Ban Frangež; T Lanišnik Rižner
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.